title: Angina pectoris refractory for conventional therapy--is neurostimulation a possible alternative treatment?
abstract: The treatment of angina pectoris as a symptom of coronary artery disease usually is focused on restoring the balance between oxygen demand and supply of the myocardium by administration of drugs interfering in heart rate, cardiac pre- and afterload, and coronary vascular tone. For nonresponders to drug therapy or for those with jeopardized myocardium, revascularization procedures such as coronary bypass surgery and percutaneous transluminal coronary angioplasty are at hand. However, the atherosclerotic process is not stopped by these therapies and, at longer terms, angina may recur. It is not always possible to revascularize all the patients who do not positively react to medical treatment. Those with angina, not responding to adequate medication and who are not suitable anymore for revascularization, are considered to suffer from refractory angina pectoris. This group of patients has a poor quality of life, for their exercise tolerance is severely afflicted. For these patients, neurostimulation has been described repeatedly as an effective and safe therapy. The mechanism of action of neurostimulation is not completely known, but recent studies suggest an anti-ischemic effect, exerted through changes in myocardial blood flow. As soon as its safety is sufficiently established, it may become a useful alternative in the treatment of refractory angina pectoris.
authors.affiliation: Department of Internal Medicine, Medisch Spectrum Twente, Enschede, The Netherlands.
authors.forename: R W
authors.initials: RW
authors.lastname: Hautvast
authors.forename: M J
authors.initials: MJ
authors.lastname: DeJongste
authors.forename: G J
authors.initials: GJ
authors.lastname: ter Horst
authors.forename: P K
authors.initials: PK
authors.lastname: Blanksma
authors.forename: K I
authors.initials: KI
authors.lastname: Lie
mesh_terms: D000787:Angina Pectoris / Q000188:drug therapy / Q000503:physiopathology / Q000628:therapy*; D003326:Coronary Circulation; D006801:Humans; D009206:Myocardium / Q000378:metabolism; D012039:Regional Blood Flow; D004561:Transcutaneous Electric Nerve Stimulation; D017211:Treatment Failure; D016896:Treatment Outcome